Recent Updates
Recently added Catalysts
AMGN Positive Sentiment Score: 65/100

AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, October 31, 2023, before the opening of the U....

Key Takeaway: Amgen (NASDAQ: AMGN) has announced its intention to report third quarter financial results on October 31, 2023, before U.S. market opening. Following the report, a conference call with the investment community will be hosted by CEO Robert A. Bradway and other senior management. The call will be broadcast live over the internet and will also be archived for replay on Amgen's website. This event highlights Amgen's continued commitment to transparency and communication with stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Amgen is scheduled to report its third quarter financial results soon.
  • The webcast will be accessible to the public, indicating transparency.
  • Amgen's commitment to innovative therapeutics and high unmet medical needs is highlighted.

Full Press Release Details

THOUSAND OAKS, Calif. , Oct. 25, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) today announced that it will report its third quarter financial results on Tuesday, October 31, 2023 , before the opening of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 5:00 a.m. PT . Participating in the call from Amgen will be Robert A. Bradway , chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME.
CONTACT: Amgen, Thousand Oaks Jessica Akopyan , 805-440-5721 (media) Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors)

21 %

Frequently Asked Questions

When will Amgen announce its Q3 financial results?

Amgen will release its Q3 financial results on October 31, 2023.

Who will participate in the Amgen conference call?

Robert A. Bradway and Amgen's senior management team will participate.

Where can I listen to the Amgen conference call?

The conference call will be available live on Amgen's website.

How long will the Amgen webcast be available for replay?

The webcast will be archived for at least 90 days after the event.

What is Amgen's mission?

Amgen aims to develop innovative therapeutics for serious illnesses.

Last updated: Oct 25, 2023